NCT07575178 Obstacle Course Versus Neuromotor Task Training in Children With DCD
| NCT ID | NCT07575178 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Developmental Coordination Disorder (DCD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2026-01-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Developmental Coordination Disorder (DCD) affects motor planning and functional mobility in children, leading to long-term functional and psychosocial difficulties. This randomized clinical trial will compare the effectiveness of Obstacle Course Training (OCT) and Neuromotor Task Training (NTT) in improving motor planning and functional mobility in children aged 7-10 years diagnosed with DCD. Participants will be randomly allocated to either OCT or NTT for 9 weeks (two sessions per week). Outcomes will be assessed using standardized motor performance measures to determine the more effective intervention.
Eligibility Criteria
Inclusion Criteria: * • Diagnosis of DCD based on DSM4/5 criteria. * Children aged 7-10. * Gender male and female. * Mini-Mental State Examination (MMSE) score \>24 . * Cognitive development appropriate for chronological age. * Raven Intelligence Test Scale (IQ \> 75) . * Developmental Coordination Questionnaire ≤48 points: likely DCD (≤ 10th percentile). * BOT-2 score ≤ 40. Exclusion Criteria: * History of surgery and lower limb injuries over the past 12 months. * Use of assistive devices to balance and walk. * Severe ADHD, Autism Spectrum Disorder (if it significantly interferes with participation), or major psychiatric disorders. * Taking neuroleptics or any other medications that significantly alter muscle tone, coordination, or attention.
Contact & Investigator
Arshmaan Mahmood, MS-PPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07575178 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 10 Years, studying Developmental Coordination Disorder (DCD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07575178 currently recruiting?
Yes, NCT07575178 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07575178 trial being conducted?
This trial is being conducted at Lahore, Pakistan, Lahore, Pakistan.
Who is sponsoring the NCT07575178 clinical trial?
NCT07575178 is sponsored by Riphah International University. The principal investigator is Arshmaan Mahmood, MS-PPT at Riphah International University. The trial plans to enroll 28 participants.